ENO2 and breast cancer: The increase in the NSE level in patients with VAS, compared with the other two groups, also confirms the data of our previous studies: due to the increase in NSE, it is possible to determine the damage to neurons and pathological activation of microglia, which are considered the leading mechanisms of cerebral disorders after breast cancer treatment [25].